(Q41919627)

14 October 2017

title

The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea (English)

1 reference

14 October 2017

0 references

1 reference

Boelaert JR

1

1 reference

14 October 2017

Sperber K

series ordinal

2

1 reference

14 October 2017

Piette J

series ordinal

3

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

14 October 2017

published in

Biochemical Pharmacology

1 reference

14 October 2017

volume

61

1 reference

14 October 2017

issue

12

1 reference

14 October 2017

page(s)

1531-1535

1 reference

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Hydroxyurea and HIV: 5 years later--from antiviral to immune-modulating effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

7 January 2021

Antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

The potential place of chloroquine in the treatment of HIV-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900576-7

10.1016/S0006-2952(01)00576-7

7 January 2021

Identifiers

DOI

1 reference

14 October 2017

1 reference